IN THE DISTRICT COURT OF APPEAL
                                      FIRST DISTRICT, STATE OF FLORIDA

OSAKATUKEI O. OMULEPU,                NOT FINAL UNTIL TIME EXPIRES TO
M.D.,                                 FILE MOTION FOR REHEARING AND
                                      DISPOSITION THEREOF IF FILED
      Petitioner,
                                      CASE NO. 1D16-1229
v.

STATE OF FLORIDA,
DEPARTMENT OF HEALTH,

      Respondent.

___________________________/

Opinion filed August 16, 2016.

Petition for Review of Non-Final Agency Action -- Original Jurisdiction.

Monica Felder Rodriguez of Rodriguez & Perry, P.A., Coral Springs, for Petitioner.

Sarah Young Hodges, Chief Appellate Counsel, Florida Department of Health,
Tallahassee, for Respondent.




PER CURIAM.

      Osakatukei O. Omulepu, M.D., petitions for review of the Order of Emergency

Restriction of License (hereafter “the ERO”) issued by the Department of Health
prohibiting him from performing liposuction or any other procedure using the

tumescent technique. 1 Dr. Omulepu argues that the ERO is facially insufficient to

justify this emergency restriction on his license because the ERO does not adequately

allege that the complained of conduct is likely to continue. We agree. Accordingly,

we quash the ERO.

      An administrative agency is authorized to issue an emergency order restricting a

license if the agency finds that “the immediate serious danger to the public health,

safety, or welfare” requires such action. § 120.60(6), Fla. Stat. (2015). “In addition to

alleging an ‘immediate serious danger,’ courts require the factual allegations of an

[emergency order] to demonstrate that ‘(1) the complained of conduct is likely to

continue; (2) the order is necessary to stop the emergency; and (3) the order is

sufficiently narrowly tailored to be fair.’” Nath v. Dep’t of Health, 

,

1276 (Fla. 1st DCA 2012) (emphasis added) (quoting Kaplan v. Dep’t of Health, 

, 21 (Fla. 1st DCA 2010)). Appellate review of an emergency order is limited

to “examining the face of the order itself to determine if the elements were alleged with

sufficient detail.” 

past conduct resulting in harm can support an emergency order

suspending or restricting a license if the harm is sufficiently egregious and of a nature

likely to be repeated. See Bio-Med Plus, Inc. v. Dep’t of Health, 

, 673



1
    We have jurisdiction.     See § 120.68(1), Fla. Stat. (2015); Fla. R. App. P.
                                         2
(Fla. 1st DCA 2005); Bertany Ass’n for Travel & Leisure, Inc. v. Dep’t of Fin. Servs.,

, 855 (Fla. 1st DCA 2004) (citing Saviak v. Gunter, 

,

1082 (Fla. 1st DCA 1979), for the proposition that “allegations of past conduct could

reflect the continuing nature of the offense”). However, where the past conduct

significantly pre-dates the emergency order and there is nothing else in the licensee’s

history that would support an inference of continuing bad conduct, allegations of past

harm standing alone are insufficient to support the emergency suspension or restriction

of a license. See Bio-Med 

; Crudele v. Nelson, 

, 880 (Fla. 1st DCA 1997); cf. Daube v. Dep’t of Health, 

, 495 (Fla.

1st DCA 2005) (granting stay of emergency suspension order because the complained

of conduct was not likely to recur and noting that “[p]unishment for past behavior is

properly the subject of an administrative complaint pursuant to section 120.60(5)

wherein the licensee is afforded the opportunity to challenge the factual basis of the

complaint through a section 120.57(1) hearing”).

      Here, the Department alleged in the ERO that Dr. Omulepu committed medical

malpractice in May 2015 when performing elective cosmetic surgery procedures on

four patients over a three-day period. 2 With respect to the likelihood that this bad



9.030(b)(1)(C), 9.190(b)(2).
2
   Three of the patients underwent a liposuction procedure commonly known as a
“Brazilian Butt Lift,” and the fourth patient underwent a different liposuction
procedure. Although the allegations of malpractice and resulting harm differed for
each patient, one common element was Dr. Omulepu’s alleged use of a tumescent
                                         3
conduct would continue, the ERO alleged only that: “The extreme number of

violations that occurred within this . . . period, which resulted in significant and lasting

patient harm, indicates that Dr. Omulepu’s conduct is likely to continue. If his conduct

continues, it will cause significant harm to his patients.”

       While there is no dispute about the seriousness of the harm allegedly suffered by

the patients listed in the ERO, the Department failed to sufficiently allege that Dr.

Omulepu’s conduct that allegedly caused that harm is of a nature that is likely to

continue. Notably, the ERO was issued in February 2016, more than nine months after

the alleged instances of malpractice, and it contains no allegations about Dr.

Omulepu’s history as a licensed physician to suggest that he has made, or is likely to

make, the same alleged errors again.

       The Department argues in response to the petition for review that Dr. Omulepu’s

past conduct is likely to continue because there is no evidence that he modified his

practices since May 2015. However, the necessary allegations to support this argument

are not contained on the face of the ERO. Moreover, as Dr. Omulepu points out in his

reply to the Department’s response, the fact that he has not been the subject of any

prior disciplinary actions, coupled with the passage of time since May 2015 without

additional reports of alleged malpractice, actually supports the contrary inference, i.e.,

that Dr. Omulepu has modified his procedures to avoid adverse outcomes such as those



solution that contained substantially less than the standard concentration of
                                       4
alleged in the ERO.

      Accordingly, for the reasons stated above, we grant Dr. Omulepu’s petition for

review and quash the ERO.

      PETITION GRANTED; ORDER QUASHED.

B.L. THOMAS, WETHERELL, and WINSOR, JJ., CONCUR.




epinephrine, which resulted in significant blood loss in each patient.
                                          5